Latest

Registers› Irish medicines ›Teva B.V.

Medicines register · Ireland

Teva B.V. — licensed medicines

171 medicines held by Teva B.V. on the Irish market, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,336 authorised products are in this register. Synced 20 Sep 2026, 17:51 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Ferric carboxymaltose Teva 50 mg iron/ml dispersion for injection/infusion PA1986/124/001

Ferric carboxymaltose

Marketed

Flecainide 100mg Tablets PA1986/050/002

Flecainide acetate

Marketed

Flecainide 50mg Tablets PA1986/050/001

Flecainide acetate

Marketed

Floxapen 1000 mg powder for solution for injection or infusion PA1986/111/003

Flucloxacillin

Marketed

Floxapen 2000 mg powder for solution for injection or infusion PA1986/111/004

Flucloxacillin

Marketed

Floxapen 250mg Powder for solution for Injection or Infusion PA1986/111/001

Flucloxacillin

Marketed

Floxapen 500 mg Powder for Solution for Injection or Infusion PA1986/111/002

Flucloxacillin

Marketed

Fluticasone Furoate Teva 27.5 micrograms/spray, nasal spray, suspension PA1986/126/001

Fluticasone furoate

Marketed

Fulvestrant Teva 250 mg Solution for Injection in Pre-filled Syringe PA1986/011/001

Fulvestrant

Marketed

Gemcitabine Teva 40 mg/ml Concentrate for Solution for Infusion PA1986/122/001

Gemcitabine

Marketed

Hydrocortone 10 mg Tablets PA1986/054/001

Hydrocortisone

Marketed

Imatinib Teva 100 mg film-coated tablets EU/1/12/808/001-012

Imatinib mesilate

—

Ipramol Steri-Neb 0.5 mg/2.5 mg per 2.5 ml nebuliser solution PA1986/082/001

Ipratropium bromide, SALBUTAMOL SULFATE

Marketed

Ipratropium Steri-Neb 250 micrograms/ml Nebuliser solution PA1986/083/001

Ipratropium bromide

Marketed

Irinotecan Hydrochloride 20 mg/mL concentrate for solution for infusion PA1986/068/001

Irinotecan hydrochloride trihydrate

Marketed

Kentera EU/1/03/270/004-005

Oxybutynin hydrochloride

—

Kentera 3.9 mg/24 hours transdermal patch EU/1/03/270/1-2

Oxybutynin

—

Lansoprazole Teva Pharma 15 mg gastro-resistant capsules, hard PA1986/008/001

Lansoprazole

Marketed

Lansoprazole Teva Pharma 30 mg gastro-resistant capsules, hard PA1986/008/002

Lansoprazole

Marketed

Lenalidomide Teva 10 mg hard capsules PA1986/051/004

Lenalidomide

Marketed

Lenalidomide Teva 15 mg hard capsules PA1986/051/005

Lenalidomide

Marketed

Lenalidomide Teva 2.5 mg hard capsules PA1986/051/001

Lenalidomide hydrochloride hydrate

Not marketed

Lenalidomide Teva 20 mg hard capsules PA1986/051/006

Lenalidomide

Marketed

Lenalidomide Teva 25 mg hard capsules PA1986/051/007

Lenalidomide

Marketed

Lenalidomide Teva 5 mg hard capsules PA1986/051/002

Lenalidomide

Marketed

Lenalidomide Teva 7.5 mg hard capsules PA1986/051/003

Lenalidomide

Not marketed

Linagliptin Teva 5 mg film-coated tablets PA1986/131/001

Linagliptin

Not marketed

Lonquex 6 mg solution for injection in pre-filled syringe EU/1/13/856/001-002

Xm22 drug substance lipegfilgrastim

—

Lonquex 6 mg/0.6 ml solution for injection EU/1/13/856/005

lipegfilgrastim

—

Lonquex 6 mg/0.6 ml solution for injection EU/1/13/856/004

lipegfilgrastim

—

Lycimor 300 mg Capsules, Hard PA1986/118/001

Lymecycline

Marketed

Motusol Max 2 % w/w gel PA1986/093/002

Diclofenac Diethylamine

Marketed

Motusol Rx 1 % w/w gel PA1986/093/001

Diclofenac Diethylamine

Not marketed

Mycophenolate mofetil Teva 250 mg Capsule, hard EU/1/07/439/1-2

Mycophenolate mofetil

—

Myfenax 250 mg Capsule, hard EU/1/07/438/1-2

Mycophenolate mofetil

—

Myfenax 500 mg Film-coated tablet EU/1/07/438/3-4

Mycophenolate mofetil

—

Nasobec 50 Micrograms Aqueous Nasal Spray PA1986/055/001

Beclometasone dipropionate

Marketed

Nasofan Aqueous 50 microgram Nasal Spray Suspension PA1986/084/001

Fluticasone propionate

Marketed

Nasusaf 137 micrograms/50 micrograms per actuation nasal spray, suspension PA1986/109/001

Azelastine hydrochloride, Fluticasone propionate

Marketed

Neotigason 10 mg capsules PA1986/113/001

Acitretin

Marketed

Neotigason 25 mg capsules PA1986/113/002

Acitretin

Marketed

Neurostil 100 mg hard capsules PA1986/128/001

Gabapentin

Not marketed

Neurostil 300 mg hard capsules PA1986/128/002

Gabapentin

Marketed

Neurostil 400 mg hard capsules PA1986/128/003

Gabapentin

Not marketed

Nortem 10mg Tablets PA1986/085/001

Temazepam

Marketed

Nortem 20mg Tablets PA1986/085/002

Temazepam

Marketed

Olatuton 10 mg powder and solvent for prolonged-release suspension for injection PA1986/076/001

Octreotide

Not marketed

Olatuton 20 mg powder and solvent for prolonged-release suspension for injection PA1986/076/002

Octreotide

Not marketed

Olatuton 30 mg powder and solvent for prolonged-release suspension for injection PA1986/076/003

Octreotide

Not marketed

Paracetamol 500 mg tablets PA1986/130/001

Paracetamol

Not marketed

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 22 September 2026. https://priyalifescience.com/medicines/company/teva-b-v

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.